Parliament’s Science and Technology Committee launched an inquiry into the impact of EU regulation and policy on the UK life sciences. The inquiry will look at how EU legislation and regulation can best facilitate, and avoid impeding, collaboration and innovation in the life sciences with particular reference to the UK life sciences sector.
Could all Professional Bodies be aware of this EU Regulation and policy on the UK life sciences. There is a need for a response within one week.
The Committee welcomes submissions by 4 March 2016 on the following issues:
• What are the key EU regulations and frameworks that govern/influence the conduct of research and innovation in the UK life sciences?
• In what ways do these EU regulations affect the UK life sciences? What are their benefits and the drawbacks?
• How transparent, consultative and evidence-based are EU policy-making processes?
• To what extent is the UK able to shape regulatory processes at the EU level that affect the life sciences?
• Is the UK able to depart from the application, standards or timing of such EU regulation?
The scope of the inquiry includes ‘medical devices’ and ‘biotechnology’
click this Link to comments page